Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.530
+0.025 (4.95%)
Last updated: Mar 10, 2026, 1:51 PM AEST

Cleo Diagnostics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23
Market Capitalization
695044-
Market Cap Growth
2.45%14.71%--
Enterprise Value
604334-
Last Close Price
0.510.390.34-
PS Ratio
26.9759.30207.25-
PB Ratio
7.838.594.65-
P/TBV Ratio
8.149.154.86-
EV/Sales Ratio
23.2950.65159.30-
Debt / Equity Ratio
----1.70
Net Debt / Equity Ratio
-1.07-1.11-1.00-1.44
Net Debt / EBITDA Ratio
2.471.612.62-0.82
Net Debt / FCF Ratio
3.742.224.61-1.88
Asset Turnover
0.290.100.04-
Quick Ratio
8.395.9319.400.13
Current Ratio
8.465.9419.410.29
Return on Equity (ROE)
-49.57%-52.53%-88.99%-
Return on Assets (ROA)
-27.12%-30.35%-41.55%-
Return on Capital Employed (ROCE)
-43.90%-70.00%-38.80%180.20%
Earnings Yield
-5.83%-7.98%-8.60%-
FCF Yield
-3.65%-5.81%-4.65%-
Buyback Yield / Dilution
-10.54%-9.53%-346.76%-
Source: S&P Capital IQ. Standard template. Financial Sources.